Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Adagio, Arcturus, Ascentage, Astrazeneca, Atai Life Science, Augmenta, Bioworks, Biocon Biologic, Biontech, Catalent, Cocrystal, Complix, Deargen, Dioscure, Dyadic International, Emergent Biosolutions, ERS Genomics, GC, Glaxosmithkline, Hillevax, I-Mab, Innarisbio, Inveniai, Jiangsu Nhwa, Johnson & Johnson, Mirum, Moderna, Oragenics, Peptidream, Pfizer, Prism Biolab, Rubic Consortium, Starpharma, Takeda, TFF, Therapeutic Solutions International, Uniquest, Unity, Vinbiocare Biotechnology Joint Stock, Vir, Zandcell.